Animal models of depression in drug discovery: a historical perspective.
Over the course of the last 50 years many models of major depressive disorder have been developed on the basis of theoretical aspects of this disorder. These models and procedures have been crucial in the discovery and development of clinically-effective drugs. Notwithstanding, there is presently great concern about the discrepancy between positive outcomes of new candidate drugs in animal models and apparent lack of efficacy in humans i.e., the predictive validity of animal models. Some reasons for this concern lie in the over-reliance in the face value of behavioural models, design of clinical trials, placebo responses, genetic variations in response to drugs, species differences in bioavailability and toxicology, and not least, disinterest of pharmaceutical sponsors to continue developing certain drugs. Present model development is focusing on endophenotypic aspects of behaviours rather than trying to model whole syndromes. This essay traces the origins and theoretical bases of our animal models of depression or depressed-like behaviours in humans and indicates how they have evolved from behavioural assays used to measure the potency and efficacy of potential candidate drugs to tools by which endophenotypes of depression may be identified and verified pharmacologically. A cautionary note is included though to indicate that the true predictive validity of our models will not be fully assessed until we can determine the attrition rate of molecules discovered from new drug targets translating into clinically-effective drugs.
McArthur
Robert
R
McArthur and Associates GmbH, Ramsteinerstrasse 28, CH-4052 Basel, Switzerland. robert.mcarthur@rmcaa.org
Borsini
Franco
F
D000818:Animals; D002490:Central Nervous System / Q000473:pathology; D002940:Circadian Rhythm; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy* / Q000473:pathology*; D004195:Disease Models, Animal; D015195:Drug Design; D006801:Humans; D051379:Mice; D008957:Models, Genetic; D009474:Neurons / Q000473:pathology; D009832:Olfactory Nerve / Q000378:metabolism*; D010641:Phenotype; D010919:Placebos
D010919:Placebos